“Pfizer & BioNtech and Moderna Inc. could receive a marketing authorization conditional of the European Union (EU) for its vaccines against Covid-19 in the second half of next month“Bloomberg reported, citing comments from the president of the European Commission, Ursula von der Leyen.
Featured quotes:
“The European Medicines Agency is in daily contact with the US Food and Drug Administration on the evaluation of vaccines in order to synchronize the evaluation.”
“If everything goes smoothly, the EMA tells us that the conditional marketing authorization for BioNTech and Moderna could occur in the second half of December 2020“.
“The Brussels-based commission is expected to reach a vaccine supply agreement with Moderna soon and is also in talks with Novavax Inc.”
Meanwhile, it is said that the EU will pay more than 9 billion euros for Pfizer and CureVac vaccinesReuters reported, citing an EU official involved in the talks.
.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
